Out of posts on Ihub, but another good Seeking Alpha

New Post Public Reply Private Reply Replies (1) Message Board
ericseb2003
Out of posts on Ihub, but another good Seeking Alpha article today on Biotech Correction seeming to be over (technically).


Optioins2Wealth new Seeking Alpha article - The Biotech Correction Is Finally Over!

Similar to an Oppenheimer call on CNBC the other day

http://seekingalpha.com/instablog/6566781-opt...on-finally

The Biotech Correction Is Finally Over!
Mar 31, 2016 2:57 AM | about stocks: IBB, ACAD, NVIV, PETX, XON, ZIOP


On Monday, July 20th, 2015, the IBB Index, which is the most followed proxy for the Biotech sector, hit an intraday high of 400.79 and 204 days later on Tuesday, Feb 9th, 2016, it notched an intraday low of 240.03, a 40% correction in less thn 7 months!

The drop was anything but gradual...

Two weeks after scoring its all-time high, the index dropped below its 50 day moving average (DMA) line support and then after another 2 weeks, it dropped below its 200 DMA line...The index made a couple of feeble attempts to regain those important support levels but failed to hold, and pretty much had been in a free-fall until it hit the intraday low of 240...

Since printing that low, the index has basically been in a consolidation mode, with the price always being significantly below its 50 DMA, which incidentally, is now its first major resistance...Only after the price of the index closes above this important moving average line for 2 consecutive days, will most market technicians feel safe enough to bet on the long side...

Today, March 30h, 2016, about 8 months after scoring its intraday high and after more than 2 months of relatively tight consolidation phase, the index, imho, gave a clear technical BUY signal...The IBB index, intraday, pierced through its 50 DMA from below, before pulling back to close down for the day...Also in the process, on its PnF chart, the index switched back into Xs and made a double-top @ 260...

(click to enlarge)

(click to enlarge)

I therefore strongly believe that the correction in the Biotech sector is technically now over and a new uptrend has begun...A close above 262 on its candlestick chart and a print of 264 on IBB's PnF chart, which will be the break of the double-top, will further confirm my hypothesis...

I expect the market to most probably flash both the confirmatory signals in the next 2 days...

But certainly by next week...

Giddy Up!

karim

DISCLAIMER: All postings made here are strictly for my personal record keeping and in no way, shape or form, am I even remotely suggesting others to follow my Buy and Sell moves. Trading options is definitely not for the faint of heart as one's portfolio can move up, or down, anywhere between 10%-30% during a single trading day. Feel free to follow my progress here, but PLEASE do not follow my moves. However, if, in spite of all my exhortations, should you decide to do so, be advised that you, and ONLY YOU will be responsible for any losses that you may suffer...In other words, the onus is strictly on you. On the other hand, if the move(s) result in a profit for you, I am open to discussing a split.

Disclosure: I am/we are long IBB, ADXS, PETX, XON, ZIOP.
Stocks: IBB, ACAD, NVIV, PETX, XON, ZIOP

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI Trust in Finance: Survey Reveals Market Impact

Updated Category News Views 1

Trust in AI for Financial Guidance: Where Are We Headed? The market winds shift with every sunrise, and today’s buzzword? Artificial Intelligence. You’d almost think AI’s trying to steal my job along with every other trader’s mojo. But here's the twist—A survey from Possible Finance shows about 15% of folks would actually lean on AI for their financial advice....

Continue Reading
Monib Zirvi's Dermatology Excellence Honored in 2026

Updated Category News Views 5

Trailblazer in Dermatology Recognized Again Fancy yourself a star in dermatology? Well, take notes from Dr. Monib A. Zirvi. The guy just got his due recognition from Marquis Who's Who for his sizable contributions to dermatology and research. For someone who's been at this game for over two decades, Zirvi doesn't just glide by on old merits. He's the real deal, and his...

Continue Reading
Helio Fred Garcia Honored by Diversity Action Alliance

Updated Category News Views 1

Award Ceremony Set in the Big Apple In an industry where recognition often feels as transient as a ticker's daily high, the Diversity Action Alliance (DAA) is doing its bit to emphasize the lasting impact individuals can make. On September 16 in New York City, Helio Fred Garcia will be honored with the 2026 Pat Ford Larger Than Life Impact Award at the DAA's Annual...

Continue Reading
EFSI Shareholders on Alert Amid M&A Deal Scrutiny

Updated Category News Views 5

Eagle Financial Services Under the Microscope A buzz is picking up in the world of mergers and acquisitions, and this time, it's Eagle Financial Services, Inc. (NASDAQ: EFSI) caught in the crosshairs. What's the chatter all about? Well, it looks like Juan Monteverde and his crew over at Monteverde & Associates PC have set their sights on Eagle's proposed sale to John...

Continue Reading
GBI Bio's New CEO Jesse McCool to Propel Growth

Updated Category News Views 1

Jesse McCool stepping into GBI's CEO shoes is the kind of move that makes you sit up straight and take notice. Let me tell you, the biomanufacturing scene is buzzing with this appointment, and McCool's got his work cut out for him in leading GBI Biomanufacturing's shift towards commercial-scale operations while expanding their early-stage biotech portfolio. A Veteran in...

Continue Reading
Atli Launches: AI-Powered eSIM Revolutionizes Travel

Updated Category News Views 2

What's New in Travel Tech: Atli's Debut Wandering the globe might sound romantic until you realize your phone's a paperweight without the right data. Enter Atli, a shiny new AI-powered travel eSIM service, snugged right into your WhatsApp. This marvel comes from the folks at XForge Mobile and aims to obliterate the hassle of getting connected abroad. You know those...

Continue Reading
Deadline Looms for EquipmentShare Investors' Legal Action

Updated Category News Views 1

Pressure Builds for EquipmentShare Investors If you've thrown some cash into EquipmentShare.com Inc. (NASDAQ: EQPT), it's time to sit up and pay attention. There's smoke on the horizon, and Faruqi & Faruqi, LLP is waving the flag. They've got a securities class action spinning fast, and if you've suffered any losses, September 21, 2026, is a date you don't want to forget....

Continue Reading
Red-Eye Flights Surge, Driven By Western U.S. Routes

Updated Category News Views 3

You can always count on some things staying the same, right? Well, if you thought red-eye flights were going to fade away, think again. These late-night wonders are not just hanging around—they're booming in the west like there's no tomorrow. Literally. Champion Traveler has laid it all out for us: about 115,580 overnight flights in 2025, a record high since this mad...

Continue Reading
Are FULC, WEAV, TECH Shareholders Getting a Raw Deal?

Updated Category News Views 4

Pocketing Insider Gains Amidst Shareholder Concerns Let me tell you, it smells like another day in the financial jungle where insiders might be feasting while the regular Joe shareholders are left nibbling on crumbs. Fulcrum Therapeutics, Weave Communications, and Bio-Techne are in the crosshairs for deals that may favor those on the inside track over you and me, the...

Continue Reading
Navigating Land Access: The Hidden Roadblock in Mining

Updated Category News Views 1

Mining's Often Overlooked Obstacle: Land Access In the world of mining, the shallow thrills of striking gold are often overshadowed by the frustrating slog of securing land access. You can have your permits lined up, your finances sorted, and drills humming along, but if you haven’t sweet-talked the folks farming above your visible vein of riches, you could be staring...

Continue Reading

Top 5 Most Recently Viewed Articles

Voltage Energy Expands Operations with New Global Headquarters

Updated Category News Views 134

Voltage Energy's Strategic Expansion Voltage Energy Group, a reputable leader in solar and clean energy solutions, has announced plans for a significant expansion. The company, founded in North Carolina in 2015, aims to make Roxboro its new Global Headquarters. This development comes alongside the establishment of a new manufacturing facility to enhance production...

Continue Reading
Exploring the Aging with the Experts Podcast by ALCA

Updated Category News Views 158

Aging Life Care Association® Launches Innovative Podcast The Aging Life Care Association (ALCA) is thrilled to announce the introduction of its new podcast series, titled Aging with the Experts. This initiative is dedicated to providing older adults, their families, and professionals in the field with valuable knowledge and support as they navigate the complexities...

Continue Reading
Innovative AERO™ Facet Fusion System Granted FDA Clearance

Updated Category News Views 257

Aurora Spine Receives FDA Clearance for AERO™ Facet Fusion System Aurora Spine Corporation, a prominent name in innovative spinal solutions, has recently attained significant recognition after securing FDA 510(k) clearance for its cutting-edge product, the AERO™ Facet Fusion System. This advancement is pivotal for their portfolio and a testament to their commitment to...

Continue Reading
Diplomatic Tensions Rise Between Brazil and Venezuela Amid Attacks

Updated Category News Views 225

Escalating Tensions Between Brazil and Venezuela Recent diplomatic exchanges between Brazil and Venezuela have taken a turn for the worse, with Brazil expressing surprise at the aggressive rhetoric used by Venezuelan authorities. The Brazilian foreign ministry's statement indicates rising tensions give way to a worrying diplomatic climate. Brazil's Stance on Venezuelan...

Continue Reading
UBS Lowers Moncler Rating as Concerns over Chinese Demand Rise

Updated Category News Views 231

UBS Lowers Moncler Stock Rating Over Concerns UBS has made a notable change by downgrading Moncler SpA's stock (BIT: MONC) from a 'Buy' to 'Neutral.' This decision is based on several factors, particularly the shifting consumer behavior and market conditions that may affect Moncler's sales in the upcoming months. Understanding UBS's Decision The main reason for this...

Continue Reading